These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33469742)

  • 41. Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily.
    Silverii GA; Monami M; Cernigliaro A; Vigneri E; Guarnotta V; Scondotto S; Allotta VA; Conti M; Giordano C; Mannucci E
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):396-398. PubMed ID: 33223405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical characteristics of the coronavirus disease 2019 (COVID-19) outbreak on a cruise ship.
    Yoshimura Y; Sasaki H; Horiuchi H; Miyata N; Tachikawa N
    J Infect Chemother; 2020 Nov; 26(11):1177-1180. PubMed ID: 32565152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters.
    Hartmann-Boyce J; Morris E; Goyder C; Kinton J; Perring J; Nunan D; Mahtani K; Buse JB; Del Prato S; Ji L; Roussel R; Khunti K
    Diabetes Care; 2020 Aug; 43(8):1695-1703. PubMed ID: 32546593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak.
    Blairon L; Mokrane S; Wilmet A; Dessilly G; Kabamba-Mukadi B; Beukinga I; Tré-Hardy M
    J Infect; 2021 Jan; 82(1):159-198. PubMed ID: 32739485
    [No Abstract]   [Full Text] [Related]  

  • 45. Coronavirus (Covid-19) outbreak on the cruise ship Diamond Princess.
    Dahl E
    Int Marit Health; 2020; 71(1):5-8. PubMed ID: 32212140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Temporal trends in voluntary behavioural changes during the early stages of the COVID-19 outbreak in Japan.
    Kashima S; Zhang J
    Public Health; 2021 Mar; 192():37-44. PubMed ID: 33611170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
    Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M
    Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autonomic dyshomeostasis in patients with diabetes mellitus during COVID-19.
    Boccardi V
    Nat Rev Endocrinol; 2021 Mar; 17(3):189. PubMed ID: 33452491
    [No Abstract]   [Full Text] [Related]  

  • 49. An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting.
    Fleming N; Sacks LJ; Pham CT; Neoh SL; Ekinci EI
    Diabet Med; 2021 Mar; 38(3):e14509. PubMed ID: 33377213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PERSEVERE OR PERIL: DIABETES CARE IN TIMES OF COVID-19.
    Barengolts E
    Endocr Pract; 2020 Jun; 26(6):688-690. PubMed ID: 32568569
    [No Abstract]   [Full Text] [Related]  

  • 51. The deterioration of mental health among healthcare workers during the COVID-19 outbreak: A population-based cohort study of workers in Japan.
    Sasaki N; Kuroda R; Tsuno K; Kawakami N
    Scand J Work Environ Health; 2020 Nov; 46(6):639-644. PubMed ID: 32905601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COVID-19 and Diabetes: Handle with Care.
    Hernández-García F
    MEDICC Rev; 2020 Oct; 22(4):7. PubMed ID: 34297710
    [No Abstract]   [Full Text] [Related]  

  • 53. Diabetes Mellitus and COVID-19: Unholy Association of Two Pandemics.
    Kamrul-Hasan AB; Nessa A; Debnath CR
    Mymensingh Med J; 2021 Jan; 30(1):1-2. PubMed ID: 33397842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mortality of the COVID-19 Outbreak in Sweden in Relation to Previous Severe Disease Outbreaks.
    Ledberg A
    Front Public Health; 2021; 9():579948. PubMed ID: 33681118
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glucovigilance in COVID-19.
    Lamptey R; Ahomagnon S; Acheampong F; Kalra S
    J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S80-S82. PubMed ID: 32515386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.
    Fadini GP; Morieri ML; Boscari F; Fioretto P; Maran A; Busetto L; Bonora BM; Selmin E; Arcidiacono G; Pinelli S; Farnia F; Falaguasta D; Russo L; Voltan G; Mazzocut S; Costantini G; Ghirardini F; Tresso S; Cattelan AM; Vianello A; Avogaro A; Vettor R
    Diabetes Res Clin Pract; 2020 Oct; 168():108374. PubMed ID: 32805345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Care for diabetes with COVID-19: Advice from China.
    Wang W; Lu J; Gu W; Zhang Y; Liu J; Ning G
    J Diabetes; 2020 May; 12(5):417-419. PubMed ID: 32285556
    [No Abstract]   [Full Text] [Related]  

  • 58. "Does having diabetes increase chances of contracting COVID-19 infection?".
    Gangopadhyay KK
    Diabetes Metab Syndr; 2020; 14(5):765-766. PubMed ID: 32512520
    [No Abstract]   [Full Text] [Related]  

  • 59. Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next.
    Angelidi AM; Belanger MJ; Mantzoros CS
    Metabolism; 2020 Jun; 107():154245. PubMed ID: 32320742
    [No Abstract]   [Full Text] [Related]  

  • 60. Molecular diagnostics at the times of SARS-CoV-2 outbreak.
    Plebani M; Lippi G
    Diagnosis (Berl); 2020 May; 7(2):149-150. PubMed ID: 32361691
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.